Ocular Therapeutix (OCUL) Leases (2019 - 2025)
Historic Leases for Ocular Therapeutix (OCUL) over the last 7 years, with Q4 2025 value amounting to $4.6 million.
- Ocular Therapeutix's Leases fell 2198.49% to $4.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.6 million, marking a year-over-year decrease of 2198.49%. This contributed to the annual value of $4.6 million for FY2025, which is 2198.49% down from last year.
- As of Q4 2025, Ocular Therapeutix's Leases stood at $4.6 million, which was down 2198.49% from $5.3 million recorded in Q3 2025.
- Ocular Therapeutix's Leases' 5-year high stood at $8.0 million during Q4 2022, with a 5-year trough of $4.0 million in Q3 2022.
- Its 5-year average for Leases is $5.8 million, with a median of $5.8 million in 2024.
- Per our database at Business Quant, Ocular Therapeutix's Leases skyrocketed by 7152.85% in 2023 and then crashed by 2198.49% in 2025.
- Over the past 5 years, Ocular Therapeutix's Leases (Quarter) stood at $4.9 million in 2021, then skyrocketed by 65.24% to $8.0 million in 2022, then decreased by 19.52% to $6.5 million in 2023, then dropped by 8.14% to $5.9 million in 2024, then dropped by 21.98% to $4.6 million in 2025.
- Its Leases was $4.6 million in Q4 2025, compared to $5.3 million in Q3 2025 and $5.9 million in Q2 2025.